2013
DOI: 10.1136/annrheumdis-2012-202208
|View full text |Cite
|
Sign up to set email alerts
|

Autoantibodies against CD74 in spondyloarthritis

Abstract: Antibodies against CD74 could provide an important additional tool for diagnosis of SpA.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
66
1
8

Year Published

2015
2015
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 81 publications
(78 citation statements)
references
References 21 publications
3
66
1
8
Order By: Relevance
“…(Hamlet, William Shakespeare). [39,40] • Proteonomics [43] • Specific Biomarkers Vascular endothelium growth factor [44] Matrix metalloproteinase-3 [45,46] Sclerostin [47,48] Calprotectin [49] Citrullinated vimentin [50] Dikkopf-1 [51] Anti-CD74 antibodies [52][53][54] 56.•• van Tubergen A. The changing clinical picture and epidemiology of spondyloarthritis.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…(Hamlet, William Shakespeare). [39,40] • Proteonomics [43] • Specific Biomarkers Vascular endothelium growth factor [44] Matrix metalloproteinase-3 [45,46] Sclerostin [47,48] Calprotectin [49] Citrullinated vimentin [50] Dikkopf-1 [51] Anti-CD74 antibodies [52][53][54] 56.•• van Tubergen A. The changing clinical picture and epidemiology of spondyloarthritis.…”
Section: Resultsmentioning
confidence: 99%
“…Appropriate assessment of criterion validity of the Bconstruct^axSpA would include verification of its biologic association with AS genetics, including MHC and non-MHC gene variants, and proteomic or other biomarkers that turn out to be typical for and occur frequently in classical AS. Candidate biomarkers, mostly hypothetical at this stage, are listed in Table 6 [39,40,[43][44][45][46][47][48][49][50][51][52][53][54]. Some of these biomarkers may turn out to have prognostic value, and those will be most suitable as predictors of outcome, not as candidates for classification criteria that are intended to create homogeneity, not prognostication.…”
Section: Moving Forward From Concept To Valid Criteriamentioning
confidence: 99%
“…Это IgG, реагирующий с пептидом инвариантной цепи (li), ассоциированной с HLA класса II (CLIP), что индуцирует активацию клеток и синтез провоспалительных цитокинов [4,17]. Антитела к CD74 рассматриваются в качестве кан-дидатного биомаркера для диагностики АС на ранней «до-рентгенологической» стадии заболевания [17,18]. При аксСпА диагностическая чувствительность (ДЧ) ис-следования антител к CD74 составляет 85,1% (HLA-B27 -77,8%), диагностическая специфичность (ДС) -92,2%, от-ношение правдоподобия положительных и отрицательных результатов (ОППР и ОПОР) -10,0 и 0,08 соответственно [17].…”
Section: аутоантителаunclassified
“…Наиболее высокая ДЧ антител к CD74 отмечается у больных аксСпА с длительностью заболевания <1 года (97%); по мере прогрессирования патологического процес-са данный показатель снижается до 69-78% [17]. Антитела к CD74 выявляются у 45% больных псориатическим артри-том без признаков поражения аксиального скелета, 11% больных РА, 15% больных системной красной волчанкой и 0,8% здоровых доноров [17,18].…”
Section: аутоантителаunclassified
“…Salmonella typhimurium Infectious bacterial pathogen Ab reactivity to lipopolysaccharides of the outer bacterial membrane Ab reactivity to antigen O [114,115] [162,163] t1:25…”
mentioning
confidence: 99%